Lowell Kabnick (USA) talks about what he is looking forward to in the upcoming Venous & Lymphatic Controversies (Superficial) session at CX 2021. He also discusses his own presentation, Is there evidence to justify an aggressive strategy for the ablation of incompetent perforators?. This controversial topic is “important to the global vascular community” because there is “not enough high-level evidence to support either side”, he says.
Kabnick further outlines some of the key highlights of both the upcoming Superficial (Monday 19 April) and Deep Venous (Wednesday 21 April) sessions.
You can register for CX 2021 here.
